Ouster Strengthens Board Compensation with New Stock Awards to Susan Heystee
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Ouster Director Susan Heystee reported acquiring 13,558 restricted stock units (RSUs) on June 18, 2025. The RSUs were granted at $0 cost and represent a contingent right to receive an equal number of common stock shares.
Key details of the transaction:
- The RSUs will vest in quarterly installments through the earlier of June 18, 2026 or the company's next annual meeting of stockholders
- Vesting is subject to Heystee's continued service as director
- Following the transaction, Heystee directly owns 90,942.3 shares of Ouster common stock
- The Form 4 was filed by attorney-in-fact Megan Chung on June 20, 2025
This equity grant appears to be part of Ouster's director compensation program, aligning the director's interests with shareholders through stock ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Heystee Susan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 13,558 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 90,942.3 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
How many OUST restricted stock units (RSUs) did Susan Heystee receive on June 18, 2025?
According to the Form 4 filing, Susan Heystee received 13,558 restricted stock units (RSUs) of Ouster, Inc. (OUST) on June 18, 2025. Each RSU represents a contingent right to receive one share of the company's common stock.
What is the vesting schedule for Susan Heystee's OUST RSUs granted in June 2025?
The RSUs vest in quarterly installments through the earlier of June 18, 2026, or Ouster's next annual meeting of stockholders, subject to Susan Heystee's continued service through the applicable vesting dates.
What is Susan Heystee's role at OUST according to the Form 4?
According to the Form 4 filing, Susan Heystee serves as a Director of Ouster, Inc. (OUST), as indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.